Home › Idiopathic Thrombocytopenic Purpura › North Carolina › Greenville
Idiopathic Thrombocytopenic Purpura clinical trials in Greenville, NC
6 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in and around Greenville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- East Carolina University, Greenville
Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia
RecruitingPhase 2
- East Carolina University, Greenville
A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
RecruitingPhase 3
- East Carolina University, Greenville
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- East Carolina University, Greenville
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
RecruitingPhase 2
- East Carolina University, Greenville
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
RecruitingPhase 3
- Brody School of Medicine at East Carolina University, Greenville
Idiopathic Thrombocytopenic Purpura trials in other cities
- Los Angeles, CA7 studies
- Boston, MA6 studies
- Washington, DC6 studies
- The Bronx, NY5 studies
- Durham, NC4 studies
- Rochester, MN4 studies
- Seattle, WA4 studies
- Houston, TX4 studies
- Portland, OR4 studies
- New Orleans, LA3 studies
- Cleveland, OH3 studies
- New Haven, CT3 studies
Other studies in Greenville
- Acute Myeloid Leukemia10 studies
- Sickle Cell Disease9 studies
- Heart Failure6 studies
- Chronic Lymphocytic Leukemia5 studies
- Burkitt Lymphoma5 studies
- Obesity5 studies
- Type 2 Diabetes5 studies
- Blood Disorders5 studies
- Cancer (all types)4 studies
- Autoimmune Diseases4 studies
- Myeloproliferative Neoplasms4 studies
- Myelodysplastic Syndromes4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.